Bortezomib injection 2mg “Towa” (Bortezomib) from Towa Pharmaceutical (YJ_code: 4291412D2020, 2mg 1 bottle) is a proteasome inhibitor indicated for the treatment of multiple myeloma and mantle cell lymphoma. It can be administered subcutaneously or intravenously.
Bortezomib injection 2mg “Towa”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →